Abstract

Recent research in Percutaneous Coronary Intervention (PCI) highlights several key advancements and refined strategies. Studies indicate that for stable multivessel coronary artery disease with reduced ejection fraction, PCI plus optimal medical therapy did not significantly improve long-term outcomes over medical therapy alone [1]. Radial access is preferred for its superior safety profile [2]. Significant progress is noted in treating chronic total occlusions [3] and with fourth-generation stents [4]. Intravascular imaging guidance improves outcomes by reducing adverse cardiac events [5]. Complex PCI requires meticulous planning [6]. Tailored dual antiplatelet therapy balances risks [7]. PCI is crucial in acute myocardial infarction [8] and cardiogenic shock [10], while comparison with coronary artery bypass grafting emphasizes individualized decisions for multivessel disease [9].